Sandoz Rituximab for Treatment of Diffuse Large B-Cell Lymphoma: Interim Safety Results of the Non-Interventional, Observational, Multicenter, Open-Label Reflect Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.120_2631

Related search